Center Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 09, 2022
Share
Center Laboratories, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 172.38 million compared to TWD 87.88 million a year ago. Net loss was TWD 1,094.25 million compared to TWD 813.42 million a year ago. Basic loss per share from continuing operations was TWD 1.674 compared to TWD 1.2828 a year ago. Diluted loss per share from continuing operations was TWD 1.674 compared to TWD 1.2828 a year ago.
For the nine months, sales was TWD 529.03 million compared to TWD 378.82 million a year ago. Net income was TWD 84.65 million compared to TWD 2,523.98 million a year ago. Basic earnings per share from continuing operations was TWD 0.1365 compared to TWD 3.9757 a year ago. Diluted earnings per share from continuing operations was TWD 0.1365 compared to TWD 3.8302 a year ago.
Center Laboratories, Inc. is a Taiwan-based company principally engaged in the production, marketing and distribution of infant nutrition products, as well as the research and development, processing, production, packaging, marketing and sales of dairy products. The Company's main products include dairy products and probiotic products. The Company is also involved in the manufacture, wholesale and retail of western medicines. The Company distributes its products in the domestic market and to overseas markets.
CENTER LABORATORIES, INC. 
